• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluating the Factors Affecting COVID-19 Patients' Mortality in Arak in 2020.评估 2020 年阿巴丹 COVID-19 患者死亡率的影响因素。
Can Respir J. 2022 Sep 16;2022:9594931. doi: 10.1155/2022/9594931. eCollection 2022.
2
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.鉴定 COVID-19 肺炎院内死亡的风险因素——来自早期爆发的教训。
BMC Infect Dis. 2021 Jan 25;21(1):113. doi: 10.1186/s12879-021-05814-4.
3
Clinical Characteristics Predicting Mortality Risk in Hospitalized Geriatric Patients with COVID-19 Pneumonia: a Retrospective Study.COVID-19 肺炎住院老年患者死亡风险的临床特征预测:一项回顾性研究。
Clin Lab. 2022 Aug 1;68(8). doi: 10.7754/Clin.Lab.2021.211054.
4
Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.意大利瓦尔卡莫尼卡地区预测 2019 年冠状病毒病(COVID-19)死亡的实验室指标。
Clin Chem Lab Med. 2020 Jun 25;58(7):1100-1105. doi: 10.1515/cclm-2020-0459.
5
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.风湿性疾病患者 COVID-19 疾病严重程度的决定因素。
Clin Rheumatol. 2020 Sep;39(9):2789-2796. doi: 10.1007/s10067-020-05301-2. Epub 2020 Jul 27.
6
Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19.与 COVID-19 相关的儿童多系统炎症综合征严重病程的危险因素。
Eur J Pediatr. 2022 Oct;181(10):3733-3738. doi: 10.1007/s00431-022-04584-8. Epub 2022 Aug 10.
7
Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.土耳其萨卡里亚市新冠肺炎危重症患者的特征和结局:一项单中心队列研究。
Turk J Med Sci. 2021 Apr 30;51(2):440-447. doi: 10.3906/sag-2005-57.
8
Can blood glucose levels predict biochemical and haematological abnormalities in COVID -19 patients - Experience from a tertiary care hospital in Balochistan.血糖水平能否预测 COVID-19 患者的生化和血液学异常——来自俾路支省一家三级护理医院的经验。
J Pak Med Assoc. 2022 Jul;72(7):1369-1372. doi: 10.47391/JPMA.3803.
9
Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.新型冠状病毒肺炎患者的急性肾损伤:城市内医院的经验及政策影响。
Am J Nephrol. 2020;51(10):786-796. doi: 10.1159/000511160. Epub 2020 Oct 2.
10
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study.新型冠状病毒肺炎与急性肾损伤的关联:一项多中心队列研究,疾病严重程度无关。
Am J Kidney Dis. 2021 Apr;77(4):490-499.e1. doi: 10.1053/j.ajkd.2020.12.007. Epub 2021 Jan 8.

引用本文的文献

1
Lactate dehydrogenase to albumin ratio and poor prognosis after thrombolysis in ischemic stroke patients: developing a novel nomogram.缺血性中风患者溶栓后乳酸脱氢酶与白蛋白比值及预后不良:构建新型列线图
BMC Med Inform Decis Mak. 2025 Apr 15;25(1):166. doi: 10.1186/s12911-025-02991-z.
2
Importance of ECG findings in COVID-19 patients: Predictor of in-hospital prognosis.心电图检查结果在新冠肺炎患者中的重要性:院内预后的预测指标。
ARYA Atheroscler. 2024 Jan-Feb;20(1):41-50. doi: 10.48305/arya.2023.41600.2887.

本文引用的文献

1
Clinical risk factors for mortality in an analysis of 1375 patients admitted for COVID treatment.分析 1375 名因 COVID 住院治疗的患者的临床死亡风险因素。
Sci Rep. 2021 Dec 3;11(1):23414. doi: 10.1038/s41598-021-02920-w.
2
Risk Factors for the Mortality in Hospitalized Patients with COVID-19: A Brief Report.COVID-19 住院患者死亡的危险因素:简要报告。
Iran J Med Sci. 2021 Nov;46(6):487-492. doi: 10.30476/IJMS.2021.47835.
3
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
4
The biological and clinical significance of emerging SARS-CoV-2 variants.新兴 SARS-CoV-2 变体的生物学和临床意义。
Nat Rev Genet. 2021 Dec;22(12):757-773. doi: 10.1038/s41576-021-00408-x. Epub 2021 Sep 17.
5
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry].[西班牙新冠肺炎住院患者的临床特征:SEMI-COVID-19登记研究结果]
Rev Clin Esp. 2020 Nov;220(8):480-494. doi: 10.1016/j.rce.2020.07.003. Epub 2020 Jul 19.
6
Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review.非洲 COVID-19 感染、疾病严重程度和相关死亡的风险因素:系统评价。
BMJ Open. 2021 Feb 18;11(2):e044618. doi: 10.1136/bmjopen-2020-044618.
7
SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.美国关注的严重急性呼吸综合征冠状病毒2变种——挑战与机遇
JAMA. 2021 Mar 16;325(11):1037-1038. doi: 10.1001/jama.2021.2294.
8
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study.COVID-19 患者 3894 例的常见心血管危险因素与住院死亡率:来自意大利多中心 CORIST 研究的生存分析和基于机器学习的发现。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913. doi: 10.1016/j.numecd.2020.07.031. Epub 2020 Jul 31.
9
Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.COVID-19 住院患者 D-二聚体升高的患病率和结局。
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2539-2547. doi: 10.1161/ATVBAHA.120.314872. Epub 2020 Aug 25.
10
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.新型冠状病毒肺炎与心血管疾病:从基础机制到临床展望。
Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20.

评估 2020 年阿巴丹 COVID-19 患者死亡率的影响因素。

Evaluating the Factors Affecting COVID-19 Patients' Mortality in Arak in 2020.

机构信息

Arak University of Medical Sciences, Arak, Iran.

Treatment Management of Social Security Organization of Khuzestan Province, Mahshahr, Iran.

出版信息

Can Respir J. 2022 Sep 16;2022:9594931. doi: 10.1155/2022/9594931. eCollection 2022.

DOI:10.1155/2022/9594931
PMID:36157971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9507664/
Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) pandemic has been a leading cause of death in the world in the last few years. This study has investigated various causes and risk factors that may lead to death due to this disease.

METHODS

From June to October 2020, 98 expired and 196 recovered patients were studied for risk factors, underlying diseases, and laboratory findings that could lead to disease progression and mortality.

RESULTS

There was a significant relationship in terms of blood pressure, age, oxygen saturation, tachycardia, tachypnea, the interval between the onset of symptoms and hospitalization, diabetes mellitus, lung disease, cardiovascular disease, history of opium abuse, C-reactive protein, white blood cell, lymphocytes, hemoglobin, creatinine elevation, elevated liver enzyme, creatine phosphokinase, lactate dehydrogenase, ferritin, D-dimer, troponin, prothrombin time, international normalized ratio, intensive care unit admission days, arrhythmia, sepsis, acute respiratory distress syndrome, acute kidney injury (AKI), and the type of antiviral and antibiotic therapy between the two groups of patients.

CONCLUSIONS

Mortality due to COVID-19 is affected by various causes such as age, underlying diseases, and complications that may occur in the course of the disease (e.g., arrhythmia, myocardial infarction, and AKI). By accurately identifying these causes and risk factors, we can prevent these complications and the mortality from COVID-19.

摘要

背景

在过去的几年中,新型冠状病毒病 2019(COVID-19)大流行是世界范围内主要的死亡原因。本研究调查了可能导致这种疾病死亡的各种原因和危险因素。

方法

2020 年 6 月至 10 月,对 98 例死亡和 196 例康复患者进行了危险因素、基础疾病和实验室检查的研究,这些检查可能导致疾病进展和死亡。

结果

血压、年龄、血氧饱和度、心动过速、呼吸急促、症状出现与住院时间间隔、糖尿病、肺部疾病、心血管疾病、鸦片滥用史、C-反应蛋白、白细胞、淋巴细胞、血红蛋白、肌酐升高、肝酶升高、肌酸磷酸激酶、乳酸脱氢酶、铁蛋白、D-二聚体、肌钙蛋白、凝血酶原时间、国际标准化比值、重症监护病房住院天数、心律失常、脓毒症、急性呼吸窘迫综合征、急性肾损伤(AKI)和抗病毒、抗生素治疗类型在两组患者之间存在显著关系。

结论

COVID-19 导致的死亡率受到年龄、基础疾病和疾病过程中可能发生的并发症等多种原因的影响(例如心律失常、心肌梗死和 AKI)。通过准确识别这些原因和危险因素,我们可以预防这些并发症和 COVID-19 的死亡率。